Related Experiment Video

Updated: Mar 22, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

760

Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass index

Antonio L Perez1, W H Wilson Tang2

  • 1Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

European Journal of Heart Failure
|April 28, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.6K

Related Experiment Videos

Last Updated: Mar 22, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

760
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.6K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

537
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
537
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K

Articles linked to this work by shared authors, journal, and citation graph.

Neonatal Ebstein anomaly national outcomes from 2000 to 2018 using the National Inpatient Sample.

Birth defects research·2021

Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy.

Journal of cardiac failure·2021

Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device.

ESC heart failure·2020

Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition.

ESC heart failure·2020

Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications.

Journal of the American Heart Association·2019

Minimally invasive biventricular mechanical circulatory support with Impella pumps as a bridge to heart transplantation: a first-in-the-world case report.

ESC heart failure·2019

Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial.

European journal of heart failure·2026

Phenotype-specific prognostic implications of pulse pressure in heart failure.

European journal of heart failure·2026

Efficacy of Vericiguat by Background Guideline-Directed Medical Therapy in the VICTOR Trial.

European journal of heart failure·2026

RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial.

European journal of heart failure·2026

Early and Late TAVI Outcomes in Aortic Stenosis with Transthyretin Cardiac Amyloidosis: A Systematic Review.

European journal of heart failure·2026

Contemporary decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials.

European journal of heart failure·2026

Effect of Surgical Subspecialty on Time to Development of Postoperative Venous Thromboembolism.

Journal of the American College of Surgeons·2026

Early versus delayed or no empagliflozin initiation after hospitalisation for heart failure in the United States: A target trial emulation.

ESC heart failure·2026

Real-world management and in-hospital outcomes of foreign body-associated esophageal perforations in the United States: a national retrospective cohort study.

Clinical endoscopy·2026

HistoWAS: A Pathomics Framework for Large-Scale Feature-Wide Association Studies of Tissue Topology and Patient Outcomes.

IS&T International Symposium on Electronic Imaging·2026

MODELING RACIAL/ETHNIC DIFFERENCES IN COVID-19 INCIDENCE WITH COVARIATES SUBJECT TO NON-RANDOM MISSINGNESS.

The annals of applied statistics·2026

Inferior pancreaticoduodenal artery aneurysm presenting as a highly vascularized lesion by the papilla Vateri: presentation of a case and review of the literature.

Journal of surgical case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us